Journal article
Research and Practice in Thrombosis and Haemostasis, 2022
APA
Click to copy
Barrett, C. D., Moore, H., Moore, E. E., Christie, D. B., Orfanos, S., Anez-Bustillos, L., … Yaffe, M. (2022). MUlticenter STudy of tissue plasminogen activator (alteplase) use in COVID‐19 severe respiratory failure (MUST COVID): A retrospective cohort study. Research and Practice in Thrombosis and Haemostasis.
Chicago/Turabian
Click to copy
Barrett, Christopher D., H. Moore, Ernest E. Moore, D. Benjamin Christie, S. Orfanos, L. Anez-Bustillos, Rashi Jhunjhunwala, et al. “MUlticenter STudy of Tissue Plasminogen Activator (Alteplase) Use in COVID‐19 Severe Respiratory Failure (MUST COVID): A Retrospective Cohort Study.” Research and Practice in Thrombosis and Haemostasis (2022).
MLA
Click to copy
Barrett, Christopher D., et al. “MUlticenter STudy of Tissue Plasminogen Activator (Alteplase) Use in COVID‐19 Severe Respiratory Failure (MUST COVID): A Retrospective Cohort Study.” Research and Practice in Thrombosis and Haemostasis, 2022.
BibTeX Click to copy
@article{christopher2022a,
title = {MUlticenter STudy of tissue plasminogen activator (alteplase) use in COVID‐19 severe respiratory failure (MUST COVID): A retrospective cohort study},
year = {2022},
journal = {Research and Practice in Thrombosis and Haemostasis},
author = {Barrett, Christopher D. and Moore, H. and Moore, Ernest E. and Christie, D. Benjamin and Orfanos, S. and Anez-Bustillos, L. and Jhunjhunwala, Rashi and Hussain, S. and Shaefi, S. and Wang, Janice and Hajizadeh, N. and Baedorf-Kassis, Elias N. and Al‐Shammaa, Ammar and Capers, Krystal and Banner-Goodspeed, V. and Wright, F. and Bull, T. and Moore, Peter K. and Nemec, Hannah M. and Buchanan, John Thomas and Nonnemacher, Cory and Rajcooar, Natalie and Ramdeo, Ramona and Yacoub, M. and Guevara, A. and Espinal, Aileen and Hattar, L. and Moraco, A. and McIntyre, R. and Talmor, D. and Sauaia, A. and Yaffe, M.}
}
Few therapies exist to treat severe COVID‐19 respiratory failure once it develops. Given known diffuse pulmonary microthrombi on autopsy studies of COVID‐19 patients, we hypothesized that tissue plasminogen activator (tPA) may improve pulmonary function in COVID‐19 respiratory failure.